Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS4,Galectin-4,Inverse variance weighted,13,1.17 [1.11-1.23],3.02977017197779e-09,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP12,Macrophage metalloelastase,Inverse variance weighted,13,1.13 [1.06-1.19],3.15951752864314e-05,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,13,1.1 [1.05-1.16],8.26057108951903e-05,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PENK,Proenkephalin-A,Inverse variance weighted,13,1.09 [1.04-1.14],0.000161236175022365,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,13,1.14 [1.07-1.22],0.000167186139023373,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.12 [1.06-1.19],0.000178797754434252,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL23,C-C motif chemokine 23,Inverse variance weighted,13,1.15 [1.07-1.24],0.000275075963422561,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,13,1.07 [1.03-1.11],0.000317428650541137,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,13,1.21 [1.09-1.34],0.000319267532568743,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,13,1.09 [1.04-1.15],0.000637828294858454,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,13,1.08 [1.03-1.13],0.000726569232104457,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,13,1.1 [1.04-1.17],0.000950851646419872,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPY,Pro-neuropeptide Y,Inverse variance weighted,13,1.18 [1.07-1.3],0.00110347156584387,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,13,1.07 [1.03-1.11],0.00116366275888687,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL22,C-C motif chemokine 22,Inverse variance weighted,13,1.12 [1.05-1.21],0.00127266538697107,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,13,1.1 [1.04-1.17],0.00128326981979429,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,1.17 [1.06-1.29],0.00155269046069045,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,13,1.06 [1.02-1.11],0.00161851966357783,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,13,1.08 [1.03-1.14],0.00172695314433614,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHRDL1,Chordin-like protein 1,Inverse variance weighted,13,1.09 [1.03-1.15],0.00178471479217855,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,13,1.1 [1.03-1.17],0.00218030720859379,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HNMT,Histamine N-methyltransferase,Inverse variance weighted,13,1.08 [1.03-1.14],0.00222549775311182,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF3,Trefoil factor 3,Inverse variance weighted,13,1.08 [1.03-1.14],0.00228056898782043,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL20,C-C motif chemokine 20,Inverse variance weighted,13,1.08 [1.03-1.14],0.00234653103963399,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANG,Angiogenin,Inverse variance weighted,13,1.07 [1.02-1.11],0.0023628627377103,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HYAL1,Hyaluronidase-1,Inverse variance weighted,13,1.07 [1.03-1.12],0.00248145789317586,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,13,1.11 [1.04-1.18],0.00250670017251017,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,13,1.13 [1.04-1.22],0.00263363674326286,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL7,C-C motif chemokine 7,Inverse variance weighted,13,1.07 [1.02-1.12],0.00273672367397972,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,13,1.06 [1.02-1.1],0.00286904257836403,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ELN,Elastin,Inverse variance weighted,13,1.05 [1.02-1.09],0.00335832426059838,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.14 [1.04-1.24],0.00399852671861967,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,13,1.09 [1.03-1.17],0.00432739848989346,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,13,1.14 [1.04-1.25],0.00449379909083914,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPPC,C-type natriuretic peptide,Inverse variance weighted,13,1.06 [1.02-1.11],0.00467600170983512,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,13,1.09 [1.03-1.15],0.00474958556115109,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,13,1.11 [1.03-1.19],0.00506915429473346,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KLK4,Kallikrein-4,Inverse variance weighted,13,1.07 [1.02-1.12],0.00516111897222394,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRSS8,Prostasin,Inverse variance weighted,13,1.09 [1.03-1.16],0.00541520157606928,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP7,Matrilysin,Inverse variance weighted,13,1.08 [1.02-1.15],0.00579748272817269,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,13,1.09 [1.02-1.15],0.00586104104873105,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFA,Protransforming growth factor alpha,Inverse variance weighted,13,1.13 [1.04-1.23],0.00603525213845482,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CST3,Cystatin-C,Inverse variance weighted,13,1.07 [1.02-1.13],0.00610558154720144,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.1 [1.03-1.18],0.00631229447716675,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,13,1.08 [1.02-1.14],0.00642586736442353,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,13,1.09 [1.02-1.16],0.00647757881966745,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CFD,Complement factor D,Inverse variance weighted,13,1.08 [1.02-1.14],0.00666318006298879,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,13,1.08 [1.02-1.15],0.0079818445602556,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,13,1.06 [1.02-1.11],0.0087077645121332,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,13,1.06 [1.01-1.11],0.00874963942874724,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL15,C-C motif chemokine 15,Inverse variance weighted,13,1.07 [1.02-1.12],0.00910427476836858,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHGB,Secretogranin-1,Inverse variance weighted,13,1.06 [1.02-1.12],0.00929257276441787,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,13,1.08 [1.02-1.14],0.00941356047885978,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300E,CMRF35-like molecule 2,Inverse variance weighted,13,1.12 [1.03-1.22],0.00946279357270132,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,13,1.13 [1.03-1.24],0.00966780239666408,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,13,1.09 [1.02-1.16],0.00993202299624174,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE4,Ribonuclease 4,Inverse variance weighted,13,1.1 [1.02-1.18],0.0100103044372024,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,13,1.08 [1.02-1.14],0.0102441001862506,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,13,1.07 [1.02-1.13],0.0105256404394369,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,13,1.09 [1.02-1.16],0.0117670257445275,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,13,1.07 [1.01-1.12],0.011927229229197,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,13,1.09 [1.02-1.16],0.0119286065048149,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,13,1.07 [1.01-1.13],0.0125119467562575,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,13,1.06 [1.01-1.11],0.012829595786311,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,13,1.08 [1.02-1.15],0.0131013244433315,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,13,1.07 [1.01-1.12],0.0135714334727913,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL16,C-C motif chemokine 16,Inverse variance weighted,13,1.08 [1.02-1.15],0.0138767723317054,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GDF15,Growth/differentiation factor 15,Inverse variance weighted,13,1.05 [1.01-1.1],0.0156419232651158,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,INHBB,Inhibin beta B chain,Inverse variance weighted,13,1.06 [1.01-1.12],0.0160220456955109,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,13,1.06 [1.01-1.12],0.0163688310536551,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,13,1.06 [1.01-1.11],0.0170032272586093,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,13,1.09 [1.02-1.18],0.0171901308235428,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,13,1.06 [1.01-1.11],0.0177387494952792,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,13,1.05 [1.01-1.09],0.0178158805408713,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,13,1.08 [1.01-1.15],0.0183858980140879,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM3C,Protein FAM3C,Inverse variance weighted,13,1.06 [1.01-1.1],0.0184363632858977,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,13,1.09 [1.01-1.17],0.0192063160637193,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RBP2,Retinol-binding protein 2,Inverse variance weighted,13,1.06 [1.01-1.11],0.0201542065623222,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CALCA,Calcitonin,Inverse variance weighted,13,1.07 [1.01-1.14],0.0204933764620356,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFTPA1,Pulmonary surfactant-associated protein A1,Inverse variance weighted,13,1.06 [1.01-1.11],0.0205125739085492,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,13,1.14 [1.02-1.27],0.0211492277835072,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASE6,Ribonuclease K6,Inverse variance weighted,13,1.07 [1.01-1.13],0.0215553934146315,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,13,1.05 [1.01-1.1],0.0217607165422726,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RTBDN,Retbindin,Inverse variance weighted,13,1.1 [1.01-1.2],0.0218101765309286,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,13,1.06 [1.01-1.1],0.0221288906379927,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF1,Trefoil factor 1,Inverse variance weighted,13,1.06 [1.01-1.11],0.0225811957167262,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,13,1.09 [1.01-1.17],0.0229019044228044,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,13,1.07 [1.01-1.13],0.0237497430896364,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,13,1.09 [1.01-1.17],0.0238468488478695,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NECTIN4,Nectin-4,Inverse variance weighted,13,1.08 [1.01-1.15],0.0240467358831532,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,STC1,Stanniocalcin-1,Inverse variance weighted,13,1.08 [1.01-1.15],0.0248161962536573,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RTN4R,Reticulon-4 receptor,Inverse variance weighted,13,1.05 [1.01-1.1],0.0260411664287869,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,13,1.06 [1.01-1.12],0.0285806818623671,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,13,1.07 [1.01-1.14],0.0288070225597808,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GOLM2,Protein GOLM2,Inverse variance weighted,13,1.09 [1.01-1.18],0.0299414337087086,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REN,Renin,Inverse variance weighted,13,1.08 [1.01-1.15],0.0304241018908839,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,13,1.06 [1.01-1.11],0.0306612882523722,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OCLN,Occludin,Inverse variance weighted,13,1.06 [1.01-1.13],0.0306965539385881,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCG2,Secretogranin-2,Inverse variance weighted,13,1.08 [1.01-1.15],0.0316274624948462,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,13,1.06 [1-1.12],0.0327343050761845,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,13,1.05 [1-1.09],0.0332133383378307,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,13,1.05 [1-1.1],0.0332639625700042,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OGN,Mimecan,Inverse variance weighted,13,1.05 [1-1.09],0.033273761919384,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,13,1.07 [1.01-1.15],0.0335719582342592,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPPB,Natriuretic peptides B,Inverse variance weighted,13,1.06 [1-1.11],0.0349153744303276,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,13,1.07 [1-1.14],0.0358331293182037,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,13,1.05 [1-1.09],0.0362255949099448,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TFF2,Trefoil factor 2,Inverse variance weighted,13,1.06 [1-1.12],0.037084037178537,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,13,1.05 [1-1.1],0.037356858126571,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,13,1.07 [1-1.14],0.0377765377674971,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,13,1.06 [1-1.12],0.0382828739617018,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPT2,Angiopoietin-2,Inverse variance weighted,13,1.06 [1-1.11],0.038355934935094,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,13,1.05 [1-1.11],0.0386070131864947,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18,Interleukin-18,Inverse variance weighted,13,1.07 [1-1.15],0.0398788371162758,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,13,1.07 [1-1.14],0.0419712166535958,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD59,CD59 glycoprotein,Inverse variance weighted,13,1.06 [1-1.11],0.0425660356741079,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,13,1.08 [1-1.16],0.0430445051870498,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,13,1.07 [1-1.14],0.0432322064738686,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADM,Pro-adrenomedullin,Inverse variance weighted,13,1.06 [1-1.11],0.0440575413286911,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AREG,Amphiregulin,Inverse variance weighted,13,1.05 [1-1.1],0.0447379451464389,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD302,CD302 antigen,Inverse variance weighted,13,1.06 [1-1.11],0.0453144481953499,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,13,1.09 [1-1.18],0.0457783972910417,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,13,1.05 [1-1.09],0.0460705813687703,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCN4,CCN family member 4,Inverse variance weighted,13,1.06 [1-1.11],0.046185421156818,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,13,1.05 [1-1.1],0.0464478278971084,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL21,C-C motif chemokine 21,Inverse variance weighted,13,1.1 [1-1.21],0.0470014933627179,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,13,1.06 [1-1.13],0.0480173351008863,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LCN15,Lipocalin-15,Inverse variance weighted,13,1.04 [1-1.09],0.0498363792698881,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,13,1.08 [1-1.17],0.0512093310862701,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AMBP,Protein AMBP,Inverse variance weighted,13,1.04 [1-1.09],0.0531208042967367,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL17C,Interleukin-17C,Inverse variance weighted,13,1.05 [1-1.1],0.0532917922151329,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,13,1.06 [1-1.13],0.0533057582594793,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,13,1.07 [1-1.14],0.0534177034451369,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,13,1.05 [1-1.1],0.0555373254451683,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,13,1.07 [1-1.16],0.0575693242571039,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,13,1.05 [1-1.11],0.0579060761907054,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS9,Galectin-9,Inverse variance weighted,13,1.09 [1-1.2],0.0600269757013483,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,13,1.06 [1-1.13],0.0605400406293816,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG1B,Lithostathine-1-beta,Inverse variance weighted,13,1.05 [1-1.11],0.0616567230871102,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,13,1.06 [1-1.14],0.0629999260304299,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,STC2,Stanniocalcin-2,Inverse variance weighted,13,1.07 [1-1.14],0.0635454480845628,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,13,1.07 [1-1.14],0.0640880952923844,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,13,1.07 [1-1.15],0.064769357045491,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEMA3F,Semaphorin-3F,Inverse variance weighted,13,1.08 [1-1.18],0.0650232965477825,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RBP5,Retinol-binding protein 5,Inverse variance weighted,13,1.06 [1-1.14],0.0654337834323177,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MFGE8,Lactadherin,Inverse variance weighted,13,1.05 [1-1.1],0.0657141500806223,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,13,1.08 [0.99-1.18],0.066554740195219,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,13,1.07 [1-1.15],0.0670956470393453,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL3,C-C motif chemokine 3,Inverse variance weighted,13,1.08 [0.99-1.18],0.067176483752818,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,13,1.06 [1-1.14],0.0682998277274431,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,13,1.05 [1-1.12],0.0690245706739332,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,13,1.08 [0.99-1.18],0.0694523881075585,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,13,1.04 [1-1.09],0.0697992371718616,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GRN,Progranulin,Inverse variance weighted,13,1.05 [1-1.12],0.0699217256818529,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PGF,Placenta growth factor,Inverse variance weighted,13,1.06 [1-1.13],0.0707713094726644,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.05 [1-1.12],0.0723656995334618,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,13,1.04 [1-1.09],0.0723699487801796,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFNA4,Ephrin-A4,Inverse variance weighted,13,1.08 [0.99-1.17],0.0727318781910874,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NOMO1,Nodal modulator 1,Inverse variance weighted,13,1.05 [0.99-1.11],0.0761442296871227,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPB6,Heat shock protein beta-6,Inverse variance weighted,13,1.05 [1-1.1],0.076882984735217,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,13,1.1 [0.99-1.22],0.0781811908174453,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,13,1.05 [0.99-1.11],0.0789728858769013,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD27,CD27 antigen,Inverse variance weighted,13,1.08 [0.99-1.18],0.0791532271779715,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,13,1.07 [0.99-1.15],0.0813707749721706,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,13,1.05 [0.99-1.11],0.0849886567483586,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,13,1.05 [0.99-1.11],0.0853804761824525,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,13,1.05 [0.99-1.11],0.0859859845892517,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DLL1,Delta-like protein 1,Inverse variance weighted,13,1.07 [0.99-1.15],0.0879764488768153,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSO,Cathepsin O,Inverse variance weighted,13,1.06 [0.99-1.13],0.0893345313464212,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,13,1.1 [0.98-1.23],0.0910325517758411,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,13,1.04 [0.99-1.09],0.0913755811034608,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,13,1.04 [0.99-1.08],0.0925477866708916,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FSTL3,Follistatin-related protein 3,Inverse variance weighted,13,1.06 [0.99-1.13],0.0930367206177543,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,13,1.05 [0.99-1.1],0.0937880866947979,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CFC1,Cryptic protein,Inverse variance weighted,13,1.04 [0.99-1.1],0.0948916461110841,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,13,1.1 [0.98-1.22],0.0984056301800213,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,13,1.05 [0.99-1.11],0.0989775338011431,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,13,1.05 [0.99-1.12],0.100619401545829,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,13,1.05 [0.99-1.11],0.101696803670228,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,13,1.08 [0.99-1.17],0.101954070308911,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,13,1.08 [0.98-1.18],0.105718516057967,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NUCB2,Nucleobindin-2,Inverse variance weighted,13,1.05 [0.99-1.11],0.106159757297075,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COLEC12,Collectin-12,Inverse variance weighted,13,1.06 [0.99-1.13],0.107037381822581,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,13,1.04 [0.99-1.09],0.107730418714749,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FURIN,Furin,Inverse variance weighted,13,1.05 [0.99-1.11],0.108973732939623,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,13,1.04 [0.99-1.09],0.109643469313614,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,13,1.05 [0.99-1.12],0.111511784723491,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DSC2,Desmocollin-2,Inverse variance weighted,13,1.06 [0.99-1.13],0.118472970109371,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,13,1.11 [0.97-1.28],0.120662997057012,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,13,1.04 [0.99-1.1],0.122703438258244,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,XCL1,Lymphotactin,Inverse variance weighted,13,1.08 [0.98-1.19],0.123562159593333,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,F9,Coagulation factor IX,Inverse variance weighted,13,1.05 [0.99-1.12],0.123969395404811,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRSS2,Trypsin-2,Inverse variance weighted,13,1.05 [0.99-1.13],0.125872581947849,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,13,1.04 [0.99-1.1],0.128242083555532,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,13,1.04 [0.99-1.09],0.129484323003905,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,13,1.06 [0.98-1.14],0.130926003606107,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,13,1.05 [0.98-1.13],0.132382565457649,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SHISA5,Protein shisa-5,Inverse variance weighted,13,1.06 [0.98-1.14],0.13265311204818,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,13,1.04 [0.99-1.08],0.134195992273556,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAYN,Layilin,Inverse variance weighted,13,1.04 [0.99-1.1],0.137767020178916,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,13,1.06 [0.98-1.14],0.138377925126878,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PALM2,Paralemmin-2,Inverse variance weighted,13,1.04 [0.99-1.11],0.13925864079357,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,13,1.05 [0.98-1.12],0.139601743719198,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LGALS1,Galectin-1,Inverse variance weighted,13,1.05 [0.98-1.12],0.139781526947094,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SDC1,Syndecan-1,Inverse variance weighted,13,1.04 [0.99-1.09],0.141822928346645,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,13,1.04 [0.99-1.09],0.142102094616475,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SNCG,Gamma-synuclein,Inverse variance weighted,13,1.03 [0.99-1.08],0.142532744465011,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,13,1.07 [0.98-1.16],0.145485213808348,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NFASC,Neurofascin,Inverse variance weighted,13,1.04 [0.98-1.11],0.1480005505268,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,B2M,Beta-2-microglobulin,Inverse variance weighted,13,1.08 [0.97-1.2],0.149703025241208,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,13,1.04 [0.99-1.09],0.149794764080251,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,13,1.08 [0.97-1.21],0.149897032641392,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PCDH1,Protocadherin-1,Inverse variance weighted,13,0.96 [0.91-1.01],0.149931625709706,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFNA1,Ephrin-A1,Inverse variance weighted,13,1.04 [0.98-1.11],0.150072207218376,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,13,1.05 [0.98-1.12],0.151925398943873,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,13,1.03 [0.99-1.08],0.152883087182452,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,13,1.04 [0.99-1.1],0.152902082686157,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,13,1.03 [0.99-1.08],0.153975651414971,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,13,1.05 [0.98-1.11],0.155943387163862,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.04 [0.98-1.1],0.15697368472282,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,13,1.04 [0.98-1.11],0.160799276942451,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VWC2,Brorin,Inverse variance weighted,13,1.05 [0.98-1.13],0.163996462474941,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,13,1.06 [0.98-1.15],0.165689456480143,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,13,1.05 [0.98-1.12],0.165743634928045,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DPY30,Protein dpy-30 homolog,Inverse variance weighted,13,1.05 [0.98-1.13],0.166018264918493,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.07 [0.97-1.17],0.167720073846813,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,13,1.04 [0.98-1.1],0.168266568465186,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,XG,Glycoprotein Xg,Inverse variance weighted,13,1.03 [0.99-1.09],0.169322468538527,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,13,1.06 [0.98-1.15],0.1694652953471,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC1,Sialoadhesin,Inverse variance weighted,13,1.06 [0.98-1.14],0.1738021232855,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.05 [0.98-1.14],0.175871300903854,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,13,1.08 [0.97-1.2],0.176226284193786,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HGF,Hepatocyte growth factor,Inverse variance weighted,13,1.07 [0.97-1.17],0.176519569066573,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,13,1.06 [0.97-1.16],0.177694525108611,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ULBP2,UL16-binding protein 2,Inverse variance weighted,13,1.03 [0.98-1.09],0.181714386370244,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,13,1.04 [0.98-1.09],0.183073147555198,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,13,1.03 [0.99-1.08],0.183094993050211,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,13,1.09 [0.96-1.23],0.184084721439932,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TCN2,Transcobalamin-2,Inverse variance weighted,13,1.03 [0.98-1.09],0.187259891214069,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MUC13,Mucin-13,Inverse variance weighted,13,1.04 [0.98-1.09],0.1877052453228,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,13,1.05 [0.98-1.12],0.188746888332544,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,THBS2,Thrombospondin-2,Inverse variance weighted,13,1.04 [0.98-1.11],0.19065370848911,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,13,1.05 [0.98-1.12],0.191920144326383,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,13,0.97 [0.92-1.02],0.192969174365767,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,13,1.05 [0.98-1.13],0.19365469768285,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF5,Fibroblast growth factor 5,Inverse variance weighted,13,0.97 [0.94-1.01],0.194386229044374,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,C7,Complement component C7,Inverse variance weighted,13,1.04 [0.98-1.1],0.195534166868441,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,13,1.04 [0.98-1.11],0.19582791585306,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,13,1.05 [0.97-1.14],0.197669582976494,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,13,1.03 [0.98-1.08],0.200052655136748,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,13,1.04 [0.98-1.09],0.200782191920302,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,13,1.05 [0.97-1.13],0.210293210884586,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,13,1.04 [0.98-1.1],0.210842643958118,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RSPO1,R-spondin-1,Inverse variance weighted,13,1.03 [0.98-1.09],0.211368936331317,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,13,1.06 [0.97-1.16],0.21150225174551,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MDK,Midkine,Inverse variance weighted,13,1.04 [0.98-1.1],0.215526100090205,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSD,Cathepsin D,Inverse variance weighted,13,1.05 [0.97-1.14],0.217272359139552,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,13,1.11 [0.94-1.3],0.217734398311584,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCL14,C-C motif chemokine 14,Inverse variance weighted,13,1.03 [0.98-1.07],0.21828507372558,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF23,Fibroblast growth factor 23,Inverse variance weighted,13,1.04 [0.97-1.12],0.222329889978842,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAM3B,Protein FAM3B,Inverse variance weighted,13,1.03 [0.98-1.08],0.224465681522165,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD7,T-cell antigen CD7,Inverse variance weighted,13,1.07 [0.96-1.2],0.22659292982706,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,13,1.04 [0.98-1.1],0.234358884183782,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GUCA2A,Guanylin,Inverse variance weighted,13,1.03 [0.98-1.09],0.237002058077666,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,13,1.03 [0.98-1.09],0.241686087339231,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,13,1.04 [0.97-1.12],0.242483506841702,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,13,1.03 [0.98-1.09],0.24599965845217,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DTNB,Dystrobrevin beta,Inverse variance weighted,13,1.04 [0.97-1.1],0.246501340584099,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.03 [0.98-1.07],0.247349339126133,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,13,1.04 [0.98-1.1],0.249590153674158,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,13,1.04 [0.97-1.11],0.251321814133168,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,13,1.03 [0.98-1.09],0.252690591096484,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,13,1.04 [0.97-1.11],0.255183164123937,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,13,1.03 [0.98-1.09],0.256067607382559,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,13,1.03 [0.98-1.07],0.260192753289066,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC3B,Tetranectin,Inverse variance weighted,13,1.04 [0.97-1.13],0.26612401684141,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,13,1.03 [0.98-1.07],0.266413177794743,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,13,0.96 [0.9-1.03],0.267671676631136,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,13,1.03 [0.97-1.1],0.268152452957916,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,13,1.03 [0.98-1.08],0.268565968012594,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,13,1.03 [0.97-1.1],0.271402805246947,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TMSB10,Thymosin beta-10,Inverse variance weighted,13,1.04 [0.97-1.13],0.274524702627808,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,13,1.02 [0.98-1.07],0.278786212802498,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,13,1.03 [0.97-1.1],0.280872721438408,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300A,CMRF35-like molecule 8,Inverse variance weighted,13,1.05 [0.96-1.15],0.28302200264731,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,13,1.05 [0.96-1.16],0.284486767503869,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,13,1.02 [0.98-1.07],0.286844558039245,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LY96,Lymphocyte antigen 96,Inverse variance weighted,13,1.05 [0.96-1.14],0.288821057718926,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,13,1.03 [0.98-1.09],0.289421727559263,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMB1,Laminin subunit beta-1,Inverse variance weighted,13,1.02 [0.98-1.07],0.291343950810095,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,13,1.03 [0.97-1.1],0.293624404820652,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,13,1.07 [0.94-1.22],0.297286685130464,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,13,0.92 [0.79-1.07],0.297402172634763,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.04 [0.96-1.13],0.297781878233168,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SLAMF8,SLAM family member 8,Inverse variance weighted,13,1.05 [0.96-1.15],0.299295260340012,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,13,1.05 [0.96-1.14],0.300108739731997,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,13,0.97 [0.93-1.02],0.30183708341968,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,13,1.02 [0.98-1.07],0.307922079761013,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,13,1.02 [0.98-1.07],0.309760927929194,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,13,1.03 [0.97-1.1],0.311878534623889,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,13,1.03 [0.97-1.09],0.312219438687593,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,13,1.07 [0.94-1.21],0.31282909790859,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,13,1.03 [0.98-1.08],0.313654525871,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,13,1.03 [0.97-1.09],0.32016414484585,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHGA,Chromogranin-A,Inverse variance weighted,13,0.97 [0.92-1.03],0.322049371696606,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD160,CD160 antigen,Inverse variance weighted,13,1.06 [0.94-1.2],0.322122101999532,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NECTIN2,Nectin-2,Inverse variance weighted,13,1.03 [0.97-1.09],0.330077015138587,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.02 [0.98-1.07],0.334836780071,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,13,1.02 [0.98-1.07],0.335792377391186,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPON1,Spondin-1,Inverse variance weighted,13,1.04 [0.96-1.14],0.33716587893925,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,13,1.02 [0.98-1.07],0.341791353521213,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.03 [0.97-1.09],0.344964439724244,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.04 [0.96-1.13],0.344998259983379,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,13,1.04 [0.96-1.12],0.345006074001875,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EGFR,Epidermal growth factor receptor,Inverse variance weighted,13,0.98 [0.94-1.02],0.345944814103283,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,13,1.03 [0.96-1.11],0.348225100738065,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,JAM2,Junctional adhesion molecule B,Inverse variance weighted,13,1.04 [0.96-1.12],0.351702199005365,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,13,1.02 [0.98-1.07],0.353118929633908,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ITGA5,Integrin alpha-5,Inverse variance weighted,13,1.06 [0.94-1.2],0.364373096700337,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FGF21,Fibroblast growth factor 21,Inverse variance weighted,13,1.03 [0.97-1.1],0.364750835652176,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,13,1.02 [0.97-1.08],0.365962862567865,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD300C,CMRF35-like molecule 6,Inverse variance weighted,13,1.05 [0.95-1.15],0.36911943143765,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,13,1.03 [0.97-1.09],0.371643146197626,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,13,1.04 [0.96-1.12],0.371705043644221,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CSTB,Cystatin-B,Inverse variance weighted,13,1.04 [0.96-1.13],0.376505013006073,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,13,1.02 [0.97-1.07],0.377734526115665,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BCAN,Brevican core protein,Inverse variance weighted,13,0.97 [0.91-1.04],0.377939756092627,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,13,1.03 [0.96-1.1],0.3793397072227,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,UMOD,Uromodulin,Inverse variance weighted,13,0.98 [0.94-1.02],0.379475930631016,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,13,1.03 [0.97-1.1],0.380222009118096,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,13,1.02 [0.97-1.08],0.387024268618662,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,13,1.03 [0.96-1.1],0.388924722836722,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,13,1.04 [0.95-1.13],0.394773658330426,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,13,1.03 [0.96-1.1],0.395452313140791,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,13,1.04 [0.95-1.13],0.400638929844016,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,13,1.05 [0.94-1.17],0.404580576020273,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PI3,Elafin,Inverse variance weighted,13,1.03 [0.97-1.09],0.410565253720327,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLMP,CXADR-like membrane protein,Inverse variance weighted,13,1.02 [0.97-1.08],0.412269843034289,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,13,1.03 [0.96-1.1],0.420018585846602,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,13,1.02 [0.97-1.08],0.421112315626351,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GAST,Gastrin,Inverse variance weighted,13,1.02 [0.97-1.07],0.425531563984105,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,13,1.02 [0.97-1.07],0.42706125787684,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,13,1.03 [0.96-1.1],0.428914944071023,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FBLN2,Fibulin-2,Inverse variance weighted,13,1.03 [0.96-1.09],0.436748760497666,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD55,Complement decay-accelerating factor,Inverse variance weighted,13,0.98 [0.94-1.03],0.451737667115129,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADA2,Adenosine deaminase 2,Inverse variance weighted,13,1.05 [0.92-1.21],0.453901653463963,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,13,1.03 [0.95-1.13],0.455141651050347,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FCRLB,Fc receptor-like B,Inverse variance weighted,13,1.02 [0.97-1.06],0.461692786614323,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ENAH,Protein enabled homolog,Inverse variance weighted,13,1.02 [0.96-1.08],0.461767708396973,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,13,1.02 [0.97-1.07],0.464599616703066,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,13,1.03 [0.95-1.11],0.465411058101015,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD83,CD83 antigen,Inverse variance weighted,13,1.04 [0.94-1.15],0.473022390645111,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CNTN5,Contactin-5,Inverse variance weighted,13,0.98 [0.94-1.03],0.479502002044087,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PLXNB2,Plexin-B2,Inverse variance weighted,13,1.03 [0.96-1.1],0.483521884050796,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,13,1.03 [0.95-1.11],0.486557710019528,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LMNB2,Lamin-B2,Inverse variance weighted,13,1.02 [0.96-1.09],0.488196198407544,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL19,Interleukin-19,Inverse variance weighted,13,1.02 [0.97-1.07],0.488593480870436,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,13,1.02 [0.96-1.09],0.490690896069422,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,13,1.01 [0.97-1.06],0.498516387273858,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,13,1.03 [0.94-1.13],0.499493308314517,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,13,1.02 [0.96-1.08],0.500993214375004,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EDN1,Endothelin-1,Inverse variance weighted,13,1.02 [0.96-1.09],0.502199496149104,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,13,0.99 [0.94-1.03],0.50416803457385,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSL,Cathepsin L1,Inverse variance weighted,13,1.02 [0.96-1.08],0.506045400555768,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH3,Cadherin-3,Inverse variance weighted,13,1.02 [0.95-1.1],0.509139162845879,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PGA4,Pepsin A-4,Inverse variance weighted,13,1.02 [0.96-1.09],0.517035640636431,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,13,1.03 [0.94-1.12],0.518281045697462,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,WNT9A,Protein Wnt-9a,Inverse variance weighted,13,0.98 [0.93-1.04],0.521664719112588,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,13,1.02 [0.96-1.09],0.524371060196451,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RNASET2,Ribonuclease T2,Inverse variance weighted,13,1.02 [0.96-1.09],0.525793938274496,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,13,0.98 [0.93-1.04],0.526826586650401,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,13,0.99 [0.94-1.03],0.527187170444766,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPP1,Osteopontin,Inverse variance weighted,13,0.98 [0.93-1.04],0.535773634760742,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD46,Membrane cofactor protein,Inverse variance weighted,13,1.02 [0.95-1.09],0.540233443398979,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,13,1.04 [0.91-1.18],0.544597919285322,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,13,1.02 [0.96-1.07],0.551621477488796,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AGRN,Agrin,Inverse variance weighted,13,1.02 [0.96-1.07],0.553099892936715,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.99 [0.94-1.04],0.564241408058705,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,13,1.04 [0.91-1.18],0.569194650217992,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD99,CD99 antigen,Inverse variance weighted,13,1.01 [0.97-1.06],0.597071116589929,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.01 [0.96-1.07],0.598639014565454,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,RSPO3,R-spondin-3,Inverse variance weighted,13,1.02 [0.94-1.1],0.61392188550589,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CTSZ,Cathepsin Z,Inverse variance weighted,13,1.02 [0.95-1.09],0.626044861588619,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FABP5,Fatty acid-binding protein 5,Inverse variance weighted,13,1.02 [0.95-1.1],0.630754373286135,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Inverse variance weighted,13,1.02 [0.95-1.09],0.632006210756648,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,13,1.01 [0.97-1.04],0.648179204216025,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD93,Complement component C1q receptor,Inverse variance weighted,13,0.99 [0.93-1.05],0.687919294376465,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL22,Interleukin-22,Inverse variance weighted,13,1.01 [0.94-1.09],0.700691959971885,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CD276,CD276 antigen,Inverse variance weighted,13,0.99 [0.93-1.05],0.713721493237027,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,13,1.01 [0.96-1.07],0.721095338343061,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,AOC3,Membrane primary amine oxidase,Inverse variance weighted,13,0.99 [0.94-1.04],0.722348399885869,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,KLK11,Kallikrein-11,Inverse variance weighted,13,1.01 [0.96-1.05],0.723438248537523,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,13,1.01 [0.94-1.1],0.729378790258036,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL15,Interleukin-15,Inverse variance weighted,13,0.98 [0.89-1.08],0.735061548296119,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH2,Cadherin-2,Inverse variance weighted,13,0.99 [0.94-1.05],0.73882863672149,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CLGN,Calmegin,Inverse variance weighted,13,0.99 [0.95-1.04],0.752089924460067,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.01 [0.95-1.07],0.753418885055492,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,13,1.01 [0.95-1.07],0.753502367714794,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,13,1.01 [0.95-1.07],0.771396007569729,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,13,1.01 [0.94-1.08],0.772823013828826,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CCN3,CCN family member 3,Inverse variance weighted,13,1.01 [0.93-1.1],0.773573288761597,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.01 [0.94-1.09],0.784265798852429,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PVR,Poliovirus receptor,Inverse variance weighted,13,0.99 [0.94-1.05],0.795065425156614,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,13,1.01 [0.97-1.05],0.795379443964372,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SEPTIN8,Septin-8,Inverse variance weighted,13,1.01 [0.95-1.07],0.79613606084314,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FOLR1,Folate receptor alpha,Inverse variance weighted,13,0.99 [0.95-1.04],0.796155994614126,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CDH1,Cadherin-1,Inverse variance weighted,13,1.01 [0.94-1.08],0.796350639324092,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,13,0.99 [0.93-1.06],0.824698436265919,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PDCD1,Programmed cell death protein 1,Inverse variance weighted,13,1.01 [0.9-1.14],0.833399103312653,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CPM,Carboxypeptidase M,Inverse variance weighted,13,1 [0.95-1.04],0.835420473340825,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CA6,Carbonic anhydrase 6,Inverse variance weighted,13,1.01 [0.95-1.06],0.843196725139229,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,13,1 [0.96-1.05],0.854327684727039,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,NEFL,Neurofilament light polypeptide,Inverse variance weighted,13,1 [0.96-1.05],0.867954593005385,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,13,1 [0.96-1.05],0.874786247702366,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,13,1 [0.95-1.04],0.881432056338169,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,CALB2,Calretinin,Inverse variance weighted,13,1 [0.92-1.08],0.906188923068888,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,13,1 [0.96-1.05],0.907108701695621,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPON2,Spondin-2,Inverse variance weighted,13,1 [0.93-1.08],0.912746922839862,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MME,Neprilysin,Inverse variance weighted,13,1 [0.96-1.04],0.928224296442488,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,PSAP,Prosaposin,Inverse variance weighted,13,1 [0.92-1.08],0.942037062495547,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GM2A,Ganglioside GM2 activator,Inverse variance weighted,13,1 [0.93-1.07],0.943171519078314,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1 [0.96-1.05],0.953262710805105,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,FSTL1,Follistatin-related protein 1,Inverse variance weighted,13,1 [0.94-1.06],0.965252188463147,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,13,1 [0.95-1.05],0.965540685651105,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,13,1 [0.96-1.04],0.975547108298232,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,BSG,Basigin,Inverse variance weighted,13,1 [0.93-1.08],0.983749683915355,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,13,1 [0.95-1.06],0.985965231817303,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MSLN,Mesothelin,Inverse variance weighted,13,1 [0.96-1.05],0.988596704141964,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,13,1 [0.95-1.05],0.99145546478595,trans
Chapter IX Diseases of the circulatory system,I9_ATHSCLE,MMP3,Stromelysin-1,Inverse variance weighted,13,1 [0.95-1.05],0.99809111480782,trans
